# A Single Dose Escalation Trial of HRS-2129 in Healthy Subjects

> **NCT06619392** · PHASE1 · COMPLETED · sponsor: **Shandong Suncadia Medicine Co., Ltd.** · enrollment: 44 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** HRS-2129
- **DRUG:** HRS-2129 Placebo

## Key facts

- **NCT ID:** NCT06619392
- **Lead sponsor:** Shandong Suncadia Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-17
- **Primary completion:** 2025-01-20
- **Final completion:** 2025-01-20
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2025-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06619392

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06619392, "A Single Dose Escalation Trial of HRS-2129 in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06619392. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*